5,7-Dichloro-2-((Ethylamino)Methyl)-8-Hydroxy-3-Methylquinazolin-4(3H)-One Methanesulfonate

1 trials Orphan designation

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

0 Completed trials

1 Sponsors

1 Countries

Phase II

Phase II: 1

Sponsors using this IMP

Alterity Therapeutics Limited 1

All trials

1 total

Open-Label Extension Study to Provide Access to ATH434 in Patients with Multiple System Atrophy Pending

2025-524317-88-00 Phase II 1 country Alterity Therapeutics Limited

Showing 1–1 of 1 trials

← All drugs A–Z